147 related articles for article (PubMed ID: 28528777)
1. Fcab-HER2 Interaction: a Ménage à Trois. Lessons from X-Ray and Solution Studies.
Lobner E; Humm AS; Göritzer K; Mlynek G; Puchinger MG; Hasenhindl C; Rüker F; Traxlmayr MW; Djinović-Carugo K; Obinger C
Structure; 2017 Jun; 25(6):878-889.e5. PubMed ID: 28528777
[TBL] [Abstract][Full Text] [Related]
2. Directed evolution of Her2/neu-binding IgG1-Fc for improved stability and resistance to aggregation by using yeast surface display.
Traxlmayr MW; Lobner E; Antes B; Kainer M; Wiederkum S; Hasenhindl C; Stadlmayr G; Rüker F; Woisetschläger M; Moulder K; Obinger C
Protein Eng Des Sel; 2013 Apr; 26(4):255-65. PubMed ID: 23267121
[TBL] [Abstract][Full Text] [Related]
3. Construction of pH-sensitive Her2-binding IgG1-Fc by directed evolution.
Traxlmayr MW; Lobner E; Hasenhindl C; Stadlmayr G; Oostenbrink C; Rüker F; Obinger C
Biotechnol J; 2014 Aug; 9(8):1013-22. PubMed ID: 24964247
[TBL] [Abstract][Full Text] [Related]
4. Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties.
Wozniak-Knopp G; Bartl S; Bauer A; Mostageer M; Woisetschläger M; Antes B; Ettl K; Kainer M; Weberhofer G; Wiederkum S; Himmler G; Mudde GC; Rüker F
Protein Eng Des Sel; 2010 Apr; 23(4):289-97. PubMed ID: 20150180
[TBL] [Abstract][Full Text] [Related]
5. Engineered IgG1-Fc--one fragment to bind them all.
Lobner E; Traxlmayr MW; Obinger C; Hasenhindl C
Immunol Rev; 2016 Mar; 270(1):113-31. PubMed ID: 26864108
[TBL] [Abstract][Full Text] [Related]
6. Two-faced Fcab prevents polymerization with VEGF and reveals thermodynamics and the 2.15 Å crystal structure of the complex.
Lobner E; Humm AS; Mlynek G; Kubinger K; Kitzmüller M; Traxlmayr MW; Djinović-Carugo K; Obinger C
MAbs; 2017 Oct; 9(7):1088-1104. PubMed ID: 28816592
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro activity of an immunoglobulin Fc fragment (Fcab) with engineered Her-2/neu binding sites.
Woisetschläger M; Antes B; Borrowdale R; Wiederkum S; Kainer M; Steinkellner H; Wozniak-Knopp G; Moulder K; Rüker F; Mudde GC
Biotechnol J; 2014 Jun; 9(6):844-51. PubMed ID: 24806546
[TBL] [Abstract][Full Text] [Related]
8. Stabilisation of the Fc fragment of human IgG1 by engineered intradomain disulfide bonds.
Wozniak-Knopp G; Stadlmann J; Rüker F
PLoS One; 2012; 7(1):e30083. PubMed ID: 22272277
[TBL] [Abstract][Full Text] [Related]
9. Generation and Biological Evaluation of Fc Antigen Binding Fragment-Drug Conjugates as a Novel Antibody-Based Format for Targeted Drug Delivery.
Jäger S; Wagner TR; Rasche N; Kolmar H; Hecht S; Schröter C
Bioconjug Chem; 2021 Aug; 32(8):1699-1710. PubMed ID: 34185508
[TBL] [Abstract][Full Text] [Related]
10. Designing Fcabs: well-expressed and stable high affinity antigen-binding Fc fragments.
Wozniak-Knopp G; Stadlmayr G; Perthold JW; Stadlbauer K; Woisetschläger M; Sun H; Rüker F
Protein Eng Des Sel; 2017 Sep; 30(9):657-671. PubMed ID: 28981753
[TBL] [Abstract][Full Text] [Related]
11. Correlation between CD16a binding and immuno effector functionality of an antigen specific immunoglobulin Fc fragment (Fcab).
Kainer M; Antes B; Wiederkum S; Wozniak-Knopp G; Bauer A; Rüker F; Woisetschläger M
Arch Biochem Biophys; 2012 Oct; 526(2):154-8. PubMed ID: 22634259
[TBL] [Abstract][Full Text] [Related]
12. Creating stable stem regions for loop elongation in Fcabs - insights from combining yeast surface display, in silico loop reconstruction and molecular dynamics simulations.
Hasenhindl C; Lai B; Delgado J; Traxlmayr MW; Stadlmayr G; Rüker F; Serrano L; Oostenbrink C; Obinger C
Biochim Biophys Acta; 2014 Sep; 1844(9):1530-40. PubMed ID: 24792385
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics simulation of the crystallizable fragment of IgG1-insights for the design of Fcabs.
Lai B; Hasenhindl C; Obinger C; Oostenbrink C
Int J Mol Sci; 2014 Jan; 15(1):438-55. PubMed ID: 24451126
[TBL] [Abstract][Full Text] [Related]
14. Structural differences between glycosylated, disulfide-linked heterodimeric Knob-into-Hole Fc fragment and its homodimeric Knob-Knob and Hole-Hole side products.
Kuglstatter A; Stihle M; Neumann C; Müller C; Schaefer W; Klein C; Benz J;
Protein Eng Des Sel; 2017 Sep; 30(9):649-656. PubMed ID: 28985438
[TBL] [Abstract][Full Text] [Related]
15. Stability assessment on a library scale: a rapid method for the evaluation of the commutability and insertion of residues in C-terminal loops of the CH3 domains of IgG1-Fc.
Hasenhindl C; Traxlmayr MW; Wozniak-Knopp G; Jones PC; Stadlmayr G; Rüker F; Obinger C
Protein Eng Des Sel; 2013 Oct; 26(10):675-82. PubMed ID: 24006374
[TBL] [Abstract][Full Text] [Related]
16. IgG2 Fc structure and the dynamic features of the IgG CH2-CH3 interface.
Teplyakov A; Zhao Y; Malia TJ; Obmolova G; Gilliland GL
Mol Immunol; 2013 Nov; 56(1-2):131-9. PubMed ID: 23628091
[TBL] [Abstract][Full Text] [Related]
17. Biochemistry, structure, and cellular internalization of a four nanobody-bearing Fc dimer.
Chabrol E; Fagnen C; Landron S; Marcheteau E; Stojko J; Guenin SP; Antoine M; Fould B; Ferry G; Boutin JA; Vénien-Bryan C
Protein Sci; 2021 Sep; 30(9):1946-1957. PubMed ID: 34117809
[TBL] [Abstract][Full Text] [Related]
18. Significant impact of single N-glycan residues on the biological activity of Fc-based antibody-like fragments.
Jez J; Antes B; Castilho A; Kainer M; Wiederkum S; Grass J; Rüker F; Woisetschläger M; Steinkellner H
J Biol Chem; 2012 Jul; 287(29):24313-9. PubMed ID: 22589538
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional characterization of MBS301, an afucosylated bispecific anti-HER2 antibody.
Huang S; Li F; Liu H; Ye P; Fan X; Yuan X; Wu Z; Chen J; Jin C; Shen B; Feng J; Zhang B
MAbs; 2018; 10(6):864-875. PubMed ID: 30081724
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of deglycosylated human IgG4-Fc.
Davies AM; Jefferis R; Sutton BJ
Mol Immunol; 2014 Nov; 62(1):46-53. PubMed ID: 24956411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
